Latest News for: c3 (complement)

Edit

Dry AMD Market Expected to rise, 2034 | Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson ...

GetNews 12 Mar 2025
Current studies primarily focus on therapies that target complement inhibitors of C3 and C5, which play a crucial role in triggering inflammation and cell death in the eye.
  • 1
×